News - Page 28 - Psychedelic Alpha

Read more about the article Does Humanity’s Fate Lie in the Hands of the Fungal Kingdom?

Does Humanity’s Fate Lie in the Hands of the Fungal Kingdom?

Post published:September 13, 2023
Post category:Opinions

Read more about the article Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD

Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD

Post published:September 12, 2023
Post category:Press Release

Read more about the article BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001

BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001

Post published:September 12, 2023
Post category:Press Release

Read more about the article Psychedelic Research Bulletin: July and August 2023

Psychedelic Research Bulletin: July and August 2023

Post published:September 9, 2023
Post category:News Psychedelics Research Review

Read more about the article Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program

Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program

Post published:September 7, 2023
Post category:Press Release

Read more about the article atai Life Sciences to Participate in Upcoming September Investor Conferences

atai Life Sciences to Participate in Upcoming September Investor Conferences

Post published:September 6, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate CMND-100 in Patients with Alcohol Use Disorder

Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate CMND-100 in Patients with Alcohol Use Disorder

Post published:September 6, 2023
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH

Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH

Post published:September 6, 2023
Post category:Press Release

Read more about the article PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX™ (Ketamine) to the FDA

PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX™ (Ketamine) to the FDA

Post published:September 6, 2023
Post category:Press Release

Read more about the article COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression

COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression

Post published:September 6, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.